Heart disease is the leading cause of death for women in the United States. Yet a new research study led by Brigham and Women’s Hospital (BWH) finds that women often remain unaware of their risk for heart disease and that differences exist in the treatment patterns and outcomes between men and women presenting with heart disease.
The study, titled “Women are Less Likely to Receive Evidence-Based Lipid Lowering Therapy: Insights from a Managed Care Population,” is co-authored by Dr. JoAnne Foody, Medical Director of the Cardiovascular Wellness Service, and Dr. Fatima Rodriguez, senior resident, Cardiovascular Medicine.
Dr. Foody and her team compared high-risk men and women treated with cholesterol-lowering medications known as statins over a four-year period. Women in the study were less likely than men to achieve optimal levels of low-density lipoprotein cholesterol (“bad” cholesterol), because they were less likely to receive treatment during the study period. The women were also less likely to receive treatment with more potent statins.